Skip to main content

Table 2 Helicobacter pylori eradication rate

From: Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial

  levofloxacin concomitant regimen doxycycline-based quadruple regimen Odds Ratio (95% CI) P-Value
ITT 82.1% 76.9% 1.371 (0.454,4.146) 0.78
PPA 82.1% 78.9% 1.219 (0.394,3.774) 0.78
  1. CI confidence interval, ITT intention to treat analysis, PPA per-protocol analysis